News
The app-based programme, developed by Neuroscience Research Australia, helped reduce fall-related injuries by 20% in clinical trials.
The app has demonstrated 93% accuracy in a nationwide study involving nearly 1,800 seniors.
The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.
The company said it plans to develop its new Chai‑2 platform to design, from square one, completely new antibodies for viruses and cancer.
The acquisition will help Datavant transition its manual health records request process to digital.
The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.
The new law bans the use of AI for mental health and therapeutic decision-making, but states it can be used for administrative and supplementary support services.
The company intends to partner with healthcare, biopharmaceutical, medical device and diagnostic companies.
The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.
The company aims to help providers secure stable pricing and access products and services for patients seeking reproductive and sexual healthcare.